Tian'an Pharmaceutical Co., Ltd.
TNPH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $3 | $2 | $107 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $6 | $337 | $5 | $289 |
| Inventory | $0 | $18 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $6 | $358 | $7 | $396 |
| Property Plant & Equip (Net) | $0 | $2 | $0 | $0 |
| Goodwill | $0 | $0 | $399 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $2 | $399 | $0 |
| Other Assets | $0 | $0 | -$399 | $0 |
| Total Assets | $6 | $360 | $7 | $396 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $62 | $57 | $182 | $176 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | -$368 | -$564 | $0 |
| Other Curr. Liab. | $30 | $736 | $590 | $347 |
| Total Curr. Liab. | $91 | $425 | $208 | $522 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $91 | $425 | $208 | $522 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $48 | $50 |
| Common Stock | $800 | $800 | $82 | $50 |
| Retained Earnings | -$7,601 | -$7,600 | -$7,570 | -$7,550 |
| AOCI | $0 | $14 | -$82 | $41 |
| Other Equity | $6,716 | $6,716 | $7,321 | $7,269 |
| Total Equity | -$86 | -$71 | -$201 | -$139 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $5 | $0 | $13 |
| Total Liab. & Tot. Equity | $6 | $360 | $7 | $396 |
| Net Debt | $62 | $54 | $180 | $68 |